GO:2000418 positive regulation of eosinophil migration: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000418 (positive regulation of eosinophil migration) describes any process that activates or increases the frequency, rate or extent of eosinophil migration, a key step in allergic and atopic inflammation.
• Eosinophil recruitment is driven by chemokines, adhesion molecules and epithelial alarmins such as thymic stromal lymphopoietin (TSLP), which can directly enhance eosinophil motility.
• TSLP promotes eosinophil migration via phosphorylation of L-plastin, linking epithelial-derived cytokines to cytoskeletal rearrangement in atopic dermatitis.
• Negative regulators exist: lactoferrin inhibits eosinophil migration, showing that the process is tightly balanced.
• Semaphorins and other guidance molecules modulate allergic inflammation and eosinophil trafficking, providing additional regulatory layers.
• Primary atopic disorders can be identified by genomic sequencing, and eosinophil migration genes are candidate contributors to these Mendelian allergy phenotypes.
Description
Eosinophils are granulocytic leukocytes that normally reside in small numbers in the bloodstream but rapidly accumulate in tissues during allergic inflammation, helminth infection and certain autoimmune conditions. Their movement from blood into tissue is not random; it is directed by a coordinated network of chemokines, adhesion receptors and activation signals that together determine where and when eosinophils extravasate. GO:2000418, positive regulation of eosinophil migration, captures the subset of biological processes that increase the frequency, rate or extent of this movement. Understanding this term is essential because eosinophil infiltration is a hallmark of asthma, atopic dermatitis, allergic rhinitis and eosinophilic esophagitis, and because therapies that block eosinophil recruitment can reduce tissue damage. The ontology term is deliberately broad: it includes cytokine-driven chemotaxis, integrin-mediated adhesion, cytoskeletal reorganization and epithelial-derived alarmin signaling. For example, thymic stromal lymphopoietin (TSLP) released from inflamed epithelium can directly enhance eosinophil migration by inducing phosphorylation of L-plastin, an actin-bundling protein. Conversely, lactoferrin, an iron-binding glycoprotein, inhibits eosinophil migration, demonstrating that positive regulation is counterbalanced by negative regulators. Semaphorins, originally described as axon guidance molecules, also modulate allergic inflammation and eosinophil trafficking. For researchers, GO:2000418 provides a precise annotation target when studying allergic disease mechanisms, testing anti-inflammatory drugs or interpreting single-cell and spatial transcriptomics data. Because eosinophil migration is a multi-step process, dissecting which genes positively regulate it requires causal experiments such as CRISPR knockout, point mutation, knock-in and overexpression in relevant cell models.
positive regulation of eosinophil migration At A Glance
| GO ID | GO:2000418 |
|---|---|
| GO term | positive regulation of eosinophil migration |
| Ontology | biological_process |
| Synonym | none |
| Major function | Activates or increases the frequency, rate or extent of eosinophil migration |
| Biological context | Allergic inflammation, atopic dermatitis, asthma, helminth immunity |
| Key upstream signals | TSLP, chemokines, adhesion molecules, semaphorins |
| Negative regulator example | Lactoferrin inhibits eosinophil migration |
| Disease relevance | Atopic dermatitis, asthma, primary atopic disorders |
What Is GO:2000418?
GO:2000418, positive regulation of eosinophil migration, is defined by QuickGO as any process that activates or increases the frequency, rate or extent of eosinophil migration. In practical terms, it covers molecular events that promote the directed movement of eosinophils, including chemokine receptor signaling, adhesion strengthening, cytoskeletal rearrangement and epithelial alarmin-driven activation.
Why Is positive regulation of eosinophil migration Important in Cell Biology?
Positive regulation of eosinophil migration is important because eosinophil tissue infiltration is a central pathogenic event in allergic and atopic diseases, and the intensity of this migration often correlates with disease severity. Defining the positive regulators of this process helps researchers identify therapeutic targets, interpret genetic variants in primary atopic disorders and design experiments that distinguish causal drivers from bystander inflammatory signals.
• Eosinophil migration is a rate-limiting step in allergic tissue inflammation.
• TSLP directly promotes eosinophil migration via L-plastin phosphorylation in atopic dermatitis.
• Lactoferrin provides a natural brake on eosinophil migration, showing the process is reversible.
• Semaphorins modulate allergic inflammation and eosinophil trafficking.
• Primary atopic disorders can be diagnosed by genomic sequencing, highlighting Mendelian control of eosinophil biology.
• Asthma pathobiology includes eosinophil recruitment to airways.
• Allergen-specific immunotherapy alters allergic inflammation and eosinophil responses.
• Type 17 mucosal-associated invariant T cells contribute to neutrophilic inflammation in nasal polyps, a related airway disease context.
• Colorectal cancer liver metastasis involves TGF-beta/Smad signaling and EMT, illustrating how migratory programs are co-opted in cancer.
• CRISPR models allow causal testing of candidate positive regulators of eosinophil migration.
What Happens During positive regulation of eosinophil migration?
Initiation by epithelial alarmins and chemokines
In simple terms: Inflamed tissue sends out chemical signals that wake up eosinophils and tell them to move.
Positive regulation of eosinophil migration begins when inflamed epithelium releases alarmins such as thymic stromal lymphopoietin (TSLP), which can act directly on eosinophils. TSLP signaling increases eosinophil motility and is associated with atopic dermatitis, a disease in which eosinophil infiltration is prominent. Chemokines and other chemoattractants cooperate with alarmins to establish a directional gradient that biases eosinophil movement toward the tissue.
Cytoskeletal rearrangement and L-plastin phosphorylation
In simple terms: The cell reshapes its internal skeleton so it can crawl forward.
Once activated, eosinophils reorganize their actin cytoskeleton to form a leading edge and a trailing uropod. TSLP promotes eosinophil migration via phosphorylation of L-plastin, an actin-bundling protein that stabilizes actin filaments and supports efficient motility. This phosphorylation event is a molecular marker of positive regulation and links epithelial alarmins to the mechanical machinery of cell movement.
Adhesion and transendothelial migration
In simple terms: The eosinophil grabs onto the blood vessel wall and squeezes through it.
Migrating eosinophils must adhere to and cross the endothelium. Positive regulation includes signals that increase integrin avidity and promote transendothelial migration, allowing eosinophils to leave the bloodstream and enter tissue. These steps are coordinated with chemokine receptor signaling so that eosinophils accumulate at the correct anatomical site.
Negative feedback and inhibitory checkpoints
In simple terms: The body also has brakes that can slow eosinophil movement down.
Positive regulation is balanced by inhibitory signals. Lactoferrin inhibits eosinophil migration, demonstrating that the process is subject to negative control. Semaphorins can also modulate allergic inflammation and eosinophil trafficking, adding another layer of regulation. Understanding these checkpoints is important because loss of inhibition could contribute to excessive eosinophil accumulation in allergic disease.
Integration with allergic inflammation networks
In simple terms: Eosinophil movement is one part of a larger allergic reaction network.
Eosinophil migration does not occur in isolation; it is integrated with adaptive and innate immune signals. Allergen-specific immunotherapy modifies allergic inflammation and can alter eosinophil responses. In asthma, eosinophil recruitment to the airways is a component of a broader pathobiological process that includes epithelial damage and airway remodeling. In nasal polyps, type 17 mucosal-associated invariant T cells contribute to neutrophilic inflammation, illustrating how related airway diseases can involve distinct but overlapping migratory programs.
Key Genes Involved in GO:2000418 positive regulation of eosinophil migration
The following genes and proteins have been reported to influence eosinophil migration or related allergic inflammatory processes and are useful candidates for functional studies of GO:2000418.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TSLP | Epithelial alarmin that promotes eosinophil migration via L-plastin phosphorylation | Direct positive regulator in atopic dermatitis models |
| LCP1 (L-plastin) | Actin-bundling protein phosphorylated downstream of TSLP | Cytoskeletal effector of eosinophil motility |
| LTF (Lactoferrin) | Iron-binding glycoprotein that inhibits eosinophil migration | Negative regulator and potential therapeutic |
| SEMA family (semaphorins) | Guidance molecules that modulate allergic inflammation | Candidate regulators of eosinophil trafficking |
| CCR3 | Chemokine receptor for eotaxin family ligands | Classic eosinophil chemotaxis receptor |
| IL5 | Cytokine that primes and activates eosinophils | Upstream activator of eosinophil responses |
| IL13 | Type 2 cytokine that promotes allergic inflammation | Indirect positive regulator of eosinophil recruitment |
| IL4 | Type 2 cytokine driving Th2 responses | Context for eosinophil-rich inflammation |
| ITGB1 | Integrin subunit mediating adhesion | Required for transendothelial migration |
| ITGB2 | Integrin subunit involved in leukocyte adhesion | Adhesion step of eosinophil migration |
| VCAM1 | Endothelial adhesion molecule | Supports eosinophil firm adhesion |
| ICAM1 | Endothelial adhesion molecule | Supports leukocyte transmigration |
| CCL11 (Eotaxin-1) | Chemokine that recruits eosinophils | Gradient-forming positive regulator |
| CCL24 (Eotaxin-2) | Chemokine that recruits eosinophils | Gradient-forming positive regulator |
| CCL26 (Eotaxin-3) | Chemokine that recruits eosinophils | Gradient-forming positive regulator |
| INHBB | TGF-beta superfamily ligand involved in EMT and metastasis | Example of migratory program co-opted in cancer |
| SMAD family | TGF-beta signaling transducers | Downstream of INHBB in migration-related EMT |
How Is positive regulation of eosinophil migration Regulated?
Positive regulation of eosinophil migration is controlled by a balance of activating and inhibitory signals. Activating inputs include epithelial alarmins such as TSLP, which promotes eosinophil migration through L-plastin phosphorylation, and chemokine gradients that orient movement. Inhibitory inputs include lactoferrin, which directly inhibits eosinophil migration, and semaphorins, which can modulate allergic inflammation and trafficking. In allergic disease, allergen-specific immunotherapy can reshape these regulatory networks and reduce eosinophil-driven inflammation. In cancer, related migratory programs such as TGF-beta/Smad-driven EMT can be co-opted by tumor cells, illustrating that migration regulation is a general biological theme.
positive regulation of eosinophil migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSLP | Atopic dermatitis | TSLP knockout or overexpression in keratinocyte-eosinophil co-culture |
| LCP1 | Atopic dermatitis | L-plastin point mutation to block phosphorylation |
| LTF | Allergic inflammation | Lactoferrin overexpression in eosinophil migration assays |
| SEMA family | Allergic diseases | Semaphorin knockout in allergic inflammation models |
| INHBB | Colorectal cancer liver metastasis | INHBB knockout in colorectal cancer cells |
Atopic dermatitis and allergic skin inflammation
Atopic dermatitis is characterized by eosinophil infiltration and epithelial-derived alarmin activity. TSLP promotes eosinophil migration via phosphorylation of L-plastin, directly linking GO:2000418 to atopic dermatitis pathogenesis. Primary atopic disorders, which can be identified by clinical landmark-guided genomic sequencing, may involve variants in genes controlling eosinophil migration.
Asthma and airway eosinophilia
Asthma pathobiology includes eosinophil recruitment to the airways, where eosinophil-derived mediators contribute to epithelial damage and airway remodeling. Positive regulation of eosinophil migration is therefore a central process in asthma and a target for anti-inflammatory strategies.
Nasal polyps and upper airway disease
Chronic rhinosinusitis with nasal polyps involves complex inflammatory cell recruitment. Type 17 mucosal-associated invariant T cells contribute to neutrophilic inflammation in nasal polyps, showing that related airway diseases can involve distinct migratory programs that intersect with eosinophil biology.
Cancer metastasis as a related migratory program
Although GO:2000418 specifically concerns eosinophils, migratory mechanisms are shared across cell types. INHBB promotes liver metastasis of colorectal cancer via TGF-beta/Smad signaling, EMT and anoikis resistance, illustrating how positive regulation of migration can be co-opted in malignancy.
From positive regulation of eosinophil migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TSLP directly promote eosinophil migration? | TSLP knockout or overexpression in epithelial-eosinophil co-culture |
| Is L-plastin phosphorylation required for eosinophil motility? | LCP1 point mutation preventing phosphorylation |
| Can lactoferrin inhibit eosinophil migration? | Lactoferrin overexpression or exogenous treatment in migration assays |
| Which semaphorins regulate eosinophil trafficking? | Semaphorin knockout or knock-in in allergic inflammation models |
| Do primary atopic disorder variants affect eosinophil migration? | Patient-derived cells with CRISPR correction of candidate variants |
| Is INHBB required for migratory EMT programs? | INHBB knockout in colorectal cancer cells |
How to Study the positive regulation of eosinophil migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Frequency and rate of eosinophil movement | Testing positive regulators such as TSLP |
| Phospho-L-plastin Western blot | Activation of L-plastin | Confirming TSLP-driven signaling |
| Live-cell imaging | Cytoskeletal dynamics and motility | Visualizing leading-edge formation |
| Genomic sequencing | Variants in candidate genes | Diagnosing primary atopic disorders |
| Lactoferrin inhibition assay | Reduction of eosinophil migration | Testing negative regulators |
| Semaphorin functional assay | Modulation of allergic inflammation | Studying guidance molecules |
| TGF-beta/Smad reporter assay | EMT and migration signaling | Modeling INHBB-driven metastasis |
| Allergen-specific immunotherapy monitoring | Changes in allergic inflammation | Evaluating eosinophil responses |
Transwell and chemotaxis assays
Transwell migration assays measure the frequency and rate of eosinophil movement across a membrane in response to chemoattractants. These assays are the standard readout for positive regulation of eosinophil migration and can be combined with cytokine or alarmin stimulation to test candidate regulators.
Phospho-proteomics and signaling analysis
Because TSLP promotes eosinophil migration via L-plastin phosphorylation, phospho-proteomic approaches can identify signaling events that positively regulate motility. Western blotting for phospho-L-plastin is a focused method for confirming pathway activation.
Live-cell imaging and cytoskeletal dynamics
Live-cell imaging of actin reporters allows researchers to visualize leading-edge formation and uropod retraction during eosinophil migration. These methods connect molecular regulators such as L-plastin to the mechanical steps of cell movement.
Genomic sequencing for primary atopic disorders
Clinical landmark-guided genomic sequencing can identify variants in genes controlling eosinophil migration in patients with primary atopic disorders. Combining sequencing with functional migration assays helps distinguish causal variants from bystanders.
How CRISPR Can Be Used to Study GO:2000418 positive regulation of eosinophil migration
Knockout
CRISPR knockout of candidate genes such as TSLP, LCP1 or LTF allows researchers to test whether they are required for positive regulation of eosinophil migration. Loss-of-function models can be evaluated in Transwell assays and phospho-L-plastin readouts.
Point Mutation
Point mutation of phosphorylation sites in LCP1 can determine whether specific phospho-residues are necessary for TSLP-driven eosinophil migration. This approach provides mechanistic resolution beyond simple knockout.
Knock-in
Knock-in of disease-associated variants identified in primary atopic disorders can test whether they alter eosinophil migration. Tagged knock-in of LCP1 can also enable live-cell imaging of the actin-bundling protein.
Overexpression
Overexpression of lactoferrin or semaphorins can test whether increasing their levels inhibits eosinophil migration. Conversely, overexpression of TSLP can enhance migration and mimic atopic dermatitis-associated inflammation.
How EDITGENE Supports positive regulation of eosinophil migration Research
Researchers studying positive regulation of eosinophil migration-related genes often need to determine whether a candidate gene is causally involved in promoting or inhibiting eosinophil movement. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point mutation, knock-in and overexpression experiments in relevant immune and epithelial cell backgrounds.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of eosinophil migration research.
Frequently Asked Questions About positive regulation of eosinophil migration
What is GO:2000418 positive regulation of eosinophil migration?
GO:2000418 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of eosinophil migration.
What genes are involved in positive regulation of eosinophil migration?
Genes include TSLP, LCP1 (L-plastin), LTF (lactoferrin), semaphorins, CCR3, IL5, IL13, CCL11, CCL24 and CCL26, among others.
How does TSLP regulate eosinophil migration?
TSLP promotes eosinophil migration via phosphorylation of L-plastin, an actin-bundling protein, in atopic dermatitis.
What inhibits eosinophil migration?
Lactoferrin inhibits eosinophil migration, providing a negative regulatory mechanism.
Why is eosinophil migration important in asthma?
Eosinophil recruitment to the airways is a component of asthma pathobiology and contributes to airway inflammation.
What diseases involve positive regulation of eosinophil migration?
Atopic dermatitis, asthma, allergic rhinitis, nasal polyps and primary atopic disorders are associated with eosinophil migration.
How can I study positive regulation of eosinophil migration in the lab?
Transwell migration assays, phospho-L-plastin Western blots, live-cell imaging and CRISPR knockout models are commonly used.
What is the role of semaphorins in allergic diseases?
Semaphorins modulate allergic inflammation and can influence eosinophil trafficking.
Can CRISPR be used to study eosinophil migration genes?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of candidate genes.
What is the connection between eosinophil migration and cancer?
Migratory programs such as TGF-beta/Smad-driven EMT are co-opted in cancer metastasis, as shown for INHBB in colorectal cancer.
Conclusion
GO:2000418 positive regulation of eosinophil migration is a focused Gene Ontology term that captures the activating signals driving eosinophil movement into tissues. Key molecular players include TSLP, L-plastin, lactoferrin and semaphorins, and the process is central to atopic dermatitis, asthma and related allergic diseases. By combining CRISPR knockout, point mutation, knock-in and overexpression models with migration assays and genomic sequencing, researchers can causally dissect which genes positively regulate eosinophil migration and prioritize therapeutic targets for allergic inflammation.
References
- 1. Niehues T et al.. 2024. Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing.. Allergol Select 8:304-323 PMID: 39381601
- 2. Bournazou I et al.. 2010. Inhibition of eosinophil migration by lactoferrin.. Immunol Cell Biol 88(2):220-3 PMID: 19918259
- 3. Ye X et al.. 2023. Type 17 mucosal-associated invariant T cells contribute to neutrophilic inflammation in patients with nasal polyps.. J Allergy Clin Immunol 152(5):1153-1166.e12 PMID: 37437744
- 4. Akdis CA et al.. 2011. Mechanisms of allergen-specific immunotherapy.. J Allergy Clin Immunol 127(1):18-27; quiz 28-9 PMID: 21211639
- 5. Naito M et al.. 2024. The role of semaphorins in allergic diseases.. Allergol Int 73(1):31-39 PMID: 37635021
- 6. Arm JP et al.. 1992. The pathobiology of bronchial asthma.. Adv Immunol 51:323-82 PMID: 1502977
- 7. Noh JY et al.. 2016. Thymic stromal lymphopoietin regulates eosinophil migration via phosphorylation of l-plastin in atopic dermatitis.. Exp Dermatol 25(11):880-886 PMID: 27304220
- 8. Yang N et al.. 2026. INHBB promotes liver metastasis of colorectal cancer via regulation of TGF-β/Smad signaling, EMT and anoikis resistance.. Tissue Cell 99:103258 PMID: 41380489
